Key TakeawaysThe Reserve Bank of Australia (RBA) maintained its cash rate, signaling a cautious stance on inflation and the economic outlook, while acknowledging potential for future policy adjustments.Global equity markets experienced a downturn, with Seoul shares declining due to tech losses and Australian shares hitting a four-month low amidst significant losses in the banking and mining sectors.Johnson & Johnson (JNJ) is set to bolster its oncology portfolio with the acquisition of Halda Therapeutics fo ...

Key TakeawaysAsian markets, including Japan's Nikkei and Topix, experienced declines as technology stocks mirrored Wall Street's downturn, with investors exercising caution ahead of key U.S. economic reports.Japan's Finance Minister Satsuki Katayama voiced strong alarm over "one-sided, rapid" forex movements, emphasizing the need for stable currency markets and indicating a forthcoming sizable economic stimulus package to counter negative GDP growth.Johnson & Johnson (JNJ) announced a significant $3.05 bill ...

Vida Ventures Marks Fourth Major Portfolio Acquisition in 2025, Capping a Record-Setting Year for Its Science-Led, Discipline-Driven Strategy Share LOS ANGELES & BOSTON--(BUSINESS WIRE)--Vida Ventures ("Vida†), a next-generation life sciences venture firm, today announced its fourth major Vida portfolio acquisition of 2025, capping an unprecedented year of strategic exits and reinforcing the firm's disciplined, science-first approach to company building and investing. Earlier today, Halda Therapeutics ann ...

The Dow Jones Industrial Average (^DJI) concluded Monday, November 17, 2025, down 557.24 (-1.18%) points, as investors reacted to a confluence of factors including upcoming earnings reports and a backlog of economic data. The market's main narrative was largely driven by the anticipation of key corporate earnings and the re-emergence of crucial economic indicators following a government shutdown. Market participants are keenly awaiting financial results from chip giant Nvidia (NVDA) later this week, seen as ...

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market update: Stocks are trading lower Monday, extending the market's recent struggle to find its footing. Concerns about stretched valuations, particularly in the technology sector, along with debt-driven spending on data centers and AI with uncertain returns, weighed on stocks. Amazon is seeking to raise $15 billion through a bond sale ...

Question-and-Answer SessionSo obviously, a lot going on at J&J. Maybe starting off with icotrokinra. So obviously, we know that there is a submission to regulators. How should we kind of think about next steps? When could we see approval? And have you guys started preparing for launch as of today?David LeeGlobal Therapeutic Area Head, Immunology for Janssen Pharmaceutical Sure. Well, I maybe will start. Let's start with icotrokinra. It's the first targeted oral peptide to the -- highly selective to the IL-2 ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Johnson & Johnson (NYSE:JNJ) 2025 Conference November 17, 2025 10:40 AM ET Company ParticipantsCandace Long - Worldwide VP of Immunology Global Commercial StrategyDavid Lee - Global Immunology Therapeutic Area HeadConference Call ParticipantsAlex Hammond - AnalystAlex HammondGood morning, everybody. My name is Alex Hammond, and I'm the biopharma analyst here at Wolfe. It's my pleasure today to have J&J. We have Candace Long, Worldwide VP Immunology Global Commercial Strategy, and we have David Lee, Global I ...

每经AI快讯，11月17日，强生涨幅扩大至1.9%，创历史新高。 （文章来源：每日经济新闻） ...

格隆汇11月17日｜强生公司股价创下历史新高，最新涨幅达 1.9%；该公司拟以30.5亿美元收购Halda， 拓展癌症业务版图。 ...